Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Semb

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Free Radical Biology & Medicine|January 1, 1997
Exogenous reactive oxygen species deplete the isolated rat heart of antioxidantsJ Vaage, M Antonelli, M Bufi, et al.
Annals of the Rheumatic Diseases|August 16, 2019
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro <i>et al</i>Rabia Agca, Sjoerd C Heslinga, S Rollefstad, et al.
Scandinavian Journal of Rheumatology|January 11, 2022
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agentsA M Kerola, S Rollefstad, A Kazemi, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritisE E A Arts, C Popa, A A Den Broeder, et al.
Journal of Internal Medicine|July 25, 2007
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery diseaseØ Bleie, A G Semb, H Grundt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases StudyS Rollefstad, E Ikdahl, J Hisdal, et al.
European Journal of Clinical Investigation|March 2, 2006
Increased inflammatory markers in children with familial hypercholesterolaemiaT Ueland, M N Vissers, A Wiegman, et al.
Scandinavian Journal of Rheumatology|March 11, 2015
Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative studyS H Sveaas, I J Berg, S A Provan, et al.
Journal of Thrombosis and Haemostasis : JTH|July 22, 2006
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled studyT Waehre, J K Damås, T M Pedersen, et al.
BMC Rheumatology|August 15, 2019
Biomarkers of cardiovascular risk across phenotypes of osteoarthritisS A Provan, S Rollefstad, E Ikdahl, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Free Radical Biology & Medicine|January 1, 1997
Exogenous reactive oxygen species deplete the isolated rat heart of antioxidantsJ Vaage, M Antonelli, M Bufi, et al.
Annals of the Rheumatic Diseases|August 16, 2019
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro <i>et al</i>Rabia Agca, Sjoerd C Heslinga, S Rollefstad, et al.
Scandinavian Journal of Rheumatology|January 11, 2022
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agentsA M Kerola, S Rollefstad, A Kazemi, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritisE E A Arts, C Popa, A A Den Broeder, et al.
Journal of Internal Medicine|July 25, 2007
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery diseaseØ Bleie, A G Semb, H Grundt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases StudyS Rollefstad, E Ikdahl, J Hisdal, et al.
European Journal of Clinical Investigation|March 2, 2006
Increased inflammatory markers in children with familial hypercholesterolaemiaT Ueland, M N Vissers, A Wiegman, et al.
Scandinavian Journal of Rheumatology|March 11, 2015
Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative studyS H Sveaas, I J Berg, S A Provan, et al.
Journal of Thrombosis and Haemostasis : JTH|July 22, 2006
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled studyT Waehre, J K Damås, T M Pedersen, et al.
BMC Rheumatology|August 15, 2019
Biomarkers of cardiovascular risk across phenotypes of osteoarthritisS A Provan, S Rollefstad, E Ikdahl, et al.
Pageof 4